JP Morgan Chase’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-7,600
Closed -$1.19M 7730
2024
Q3
$1.19M Buy
+7,600
New +$1.17M ﹤0.01% 4358
2024
Q2
Sell
-30,000
Closed -$2.22M 7744
2024
Q1
$2.22M Buy
+30,000
New +$2.47M ﹤0.01% 3749

Other funds holding TMDX

JP Morgan Chase's TMDX Position: Q1 2026 in Review

JP Morgan Chase reduced its Transmedics (TMDX) stake by 18% in Q1 2026, selling an estimated $8.73M and leaving 308,341 shares worth $29.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1763.

JP Morgan Chase first reported a position in TMDX in Q2 2019 and has held it in 28 quarters since. The position peaked at $62.2M in Q2 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • JP Morgan Chase held 308,341 shares of Transmedics worth $29.1M as of Q1 2026.
  • JP Morgan Chase sold 66,920 Transmedics shares in Q1 2026, an estimated $8.73M.
  • Transmedics made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #1763 holding.
  • JP Morgan Chase first reported a position in Transmedics in Q2 2019 and has held it in 28 quarters since.
  • JP Morgan Chase's Transmedics position peaked at $62.2M in Q2 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.